Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

April 15, 2015

Primary Completion Date

September 26, 2016

Study Completion Date

July 6, 2020

Conditions
Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
Interventions
DRUG

MEDI4736

MEDI4736 monotherapy

DRUG

Tremelimumab

Tremelimumab monotherapy

DRUG

MEDI4736 + Tremelimumab

MEDI4736 + Tremelimumab combination therapy

Trial Locations (125)

1077

Research Site, Budapest

1083

Research Site, Budapest

1090

Research Site, Brussels

1122

Research Site, Budapest

2010

Research Site, Darlinghurst

2485

Research Site, Tweed Heads

3000

Research Site, Leuven

3526

Research Site, Miskolc

5000

Research Site, Adelaide

Research Site, Namur

5700

Research Site, Gyula

6000

Research Site, Charleroi

Research Site, Kecskemét

6010

Research Site, Batumi

6189

Research Site, Nice

6400

Research Site, Batumi

8500

Research Site, Kortrijk

8900

Research Site, Zalaegerszeg

9024

Research Site, Győr

10032

Research Site, New York

10408

Research Site, Goyang-si

10449

Research Site, Taipei

10467

Research Site, The Bronx

11794

Research Site, Stony Brook

12203

Research Site, Berlin

15232

Research Site, Pittsburgh

16247

Research Site, Suwon

17007

Research Site, Girona

18014

Research Site, Granada

18015

Research Site, Bethlehem

21079

Research Site, Dijon

21201

Research Site, Baltimore

21204

Research Site, Baltimore

22015

Research Site, Saint-Brieuc

23007

Research Site, Jaén

26506

Research Site, Morgantown

27157

Research Site, Winston-Salem

27705

Research Site, Durham

28041

Research Site, Madrid

28046

Research Site, Madrid

28050

Research Site, Madrid

29010

Research Site, Málaga

29229

Research Site, Brest

29425

Research Site, Charleston

29600

Research Site, Marbella (Málaga)

30322

Research Site, Atlanta

30625

Research Site, Hanover

30912

Research Site, Augusta

31059

Research Site, Toulouse

31096

Research Site, Haifa

31201

Research Site, Macon

33604

Research Site, Bordeaux

33612

Research Site, Tampa

34298

Research Site, Montpellier

35294

Research Site, Birmingham

35768

Research Site, Saint-Grégoire

37232

Research Site, Nashville

37909

Research Site, Knoxville

42601

Research Site, Daegu

46014

Research Site, Valencia

46026

Research Site, Valencia

48075

Research Site, Southfield

48109

Research Site, Ann Arbor

48201

Research Site, Detroit

48903

Research Site, Barakaldo

49933

Research Site, Angers

50009

Research Site, Zaragoza

52621

Research Site, Tel Litwinsky

53226

Research Site, Milwaukee

56322

Research Site, Lorient

59020

Research Site, Lille

59100

Research Site, Kuala Lumpur

60201

Research Site, Evanston

60637

Research Site, Chicago

63110

Research Site, St Louis

67085

Research Site, Strasbourg

69120

Research Site, Heidelberg

69373

Research Site, Lyon

72000

Research Site, Le Mans

72205

Research Site, Little Rock

75230

Research Site, Dallas

76012

Research Site, Arlington

76038

Research Site, Rouen

78701

Research Site, Austin

80045

Research Site, Aurora

81377

Research Site, München

85364

Research Site, Yuma

90033

Research Site, Los Angeles

90095

Research Site, Los Angeles

90241

Research Site, Downey

90813

Research Site, Long Beach

92093

Research Site, La Jolla

93586

Research Site, Kuching

94115

Research Site, San Francisco

94805

Research Site, Villejuif

97239

Research Site, Portland

4941492

Research Site, Petah Tikva

91010-3012

Research Site, Duarte

40536-0001

Research Site, Lexington

02215

Research Site, Boston

55905-0001

Research Site, Rochester

03756

Research Site, Lebanon

T2N 2T9

Research Site, Calgary

E1C 6Z8

Research Site, Moncton

N6A 4L6

Research Site, London

K1H 8L6

Research Site, Ottawa

M5G 2M9

Research Site, Toronto

H4A 3J1

Research Site, Montreal

J1H 5N4

Research Site, Sherbrooke

775 20

Research Site, Olomouc

762 75

Research Site, Zlín

0144

Research Site, Tbilisi

0177

Research Site, Tbilisi

0179

Research Site, Tbilisi

06120

Research Site, Halle

04103

Research Site, Leipzig

08035

Research Site, Barcelona

08036

Research Site, Barcelona

08907

Research Site, Barcelona

AB25 2ZN

Research Site, Aberdeen

B15 2TH

Research Site, Birmingham

G12 0YN

Research Site, Glasgow

E1 1BB

Research Site, London

M20 4BX

Research Site, Manchester

CH63 4JY

Research Site, Metropolitan Borough of Wirral

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

AstraZeneca

INDUSTRY